Jason Huse

University of Texas at Houston - Department of Pathology

University of Texas MD Anderson Cancer Center - Department of Neuropathology

TX

United States

SCHOLARLY PAPERS

3

DOWNLOADS

67

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Window-of-Opportunity Clinical Trial of Pembrolizumab in Recurrent Glioblastoma (GBM) Patients

Number of pages: 99 Posted: 14 Oct 2018
University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuro-Oncology, Baylor University, College of Medicine, Department of Neurology, University of Texas at Houston - Department of Biostatistics, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Neuropathology, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston, Health Science Center at Houston (UTHealth), MD Anderson Cancer Center, Department of Radiology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology, University of Texas at Houston - Department of Immunology and University of Texas at Houston - Department of Neurosurgery
Downloads 39 (861,076)

Abstract:

Loading...

glioblastoma, immune checkpoint inhibitor, clinical trial, PD-1

2.

Glial Cell Adhesion Molecule (GlialCAM) and Aquaporin-4 Coordinately Drive Glioblastoma Cell Invasion in the Brain

Number of pages: 57 Posted: 21 Mar 2023
University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Bioinformatics and Computational Biology, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Neurosurgery, University of Texas at Houston - Department of Pathology, University of Texas at Houston - Department of Neurosurgery and University of Texas at Houston - Department of Neurosurgery
Downloads 19 (1,060,843)

Abstract:

Loading...

extracellular matrix, astrocyte, hepaCAM, angiogenesis, brain cancer, AQP4, megalencephalic leukoencephalopathy with subcortical cysts 1 (Mlc1)

3.

ATRX Loss in Glioma Results in Epigenetic Dysregulation of Cell Cycle Phase Transition

Number of pages: 56 Posted: 22 Jun 2021
University of Michigan Medical School - Department of Computational Medicine and Bioinformatics, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, Kansas State University - Division of Biology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, Johns Hopkins University School of Medicine - Department of Pathology, University of Michigan Medical School - Department of Pathology, University of Michigan Medical School - Department of Radiation Oncology, University of Michigan Medical School - Department of Radiation Oncology, University of Michigan Medical School - Department of Computational Medicine and Bioinformatics, University of Michigan Medical School - Department of Pathology, Johns Hopkins University School of Medicine - Department of Pathology, University of Texas at Houston - Department of Pathology, University of Michigan Medical School - Department of Radiation Oncology, University of Michigan Medical School - Departments of Neurosurgery and Cell and Developmental Biology, University of Michigan Medical School - Departments of Neurosurgery and Cell and Developmental Biology, University of Michigan Medical School - Division of Pediatric Hematology-Oncology and University of Michigan Medical School - Division of Pediatric Hematology-Oncology
Downloads 9 (1,183,770)

Abstract:

Loading...

Glioma, Cell-cycle, Epigenetics, ATRX, ATM inhibitor, CHEK1